Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe

  • Martins Kalejs1Email author,
  • Andrey Ivanov1, 2,
  • Gregory Plakhins1,
  • Mark S Cragg3, 4,
  • Dzintars Emzinsh5,
  • Timothy M Illidge2 and
  • Jekaterina Erenpreisa1
Contributed equally
BMC Cancer20066:6

DOI: 10.1186/1471-2407-6-6

Received: 30 September 2005

Accepted: 09 January 2006

Published: 09 January 2006



We have previously reported that p53 mutated radioresistant lymphoma cell lines undergo mitotic catastrophe after irradiation, resulting in metaphase arrest and the generation of endopolyploid cells. A proportion of these endopolyploid cells then undergo a process of de-polyploidisation, stages of which are partially reminiscent of meiotic prophase. Furthermore, expression of meiosis-specific proteins of the cancer/testis antigens group of genes has previously been reported in tumours. We therefore investigated whether expression of meiosis-specific genes was associated with the polyploidy response in our tumour model.


Three lymphoma cell lines, Namalwa, WI-L2-NS and TK6, of varying p53 status were exposed to a single 10 Gy dose of gamma radiation and their responses assessed over an extended time course. DNA flow cytometry and mitotic counts were used to assess the kinetics and extent of polyploidisation and mitotic progression. Expression of meiotic genes was analysed using RT-PCR and western blotting. In addition, localisation of the meiotic cohesin REC8 and its relation to centromeres was analysed by immunofluorescence.


The principal meiotic regulator MOS was found to be significantly post-transcriptionally up-regulated after irradiation in p53 mutated but not p53 wild-type lymphoma cells. The maximum expression of MOS coincided with the maximal fraction of metaphase arrested cells and was directly proportional to both the extent of the arrest and the number of endopolyploid cells that subsequently emerged. The meiotic cohesin REC8 was also found to be up-regulated after irradiation, linking sister chromatid centromeres in the metaphase-arrested and subsequent giant cells. Finally, RT-PCR revealed expression of the meiosis-prophase genes, DMC1, STAG3, SYCP3 and SYCP1.


We conclude that multiple meiotic genes are aberrantly activated during mitotic catastrophe in p53 mutated lymphoma cells after irradiation. Furthermore, we suggest that the coordinated expression of MOS and REC8 regulate the extent of arrested mitoses and polyploidy.


DNA damage induces a G2 phase cell-cycle arrest in most tumour cell lines that lack functional p53 protein. Following abrogation of the G2 checkpoint, these cells arrest in mitosis and can subsequently form polyploid cells. This response is thought to represent an alternative to immediate death through apoptosis. This abnormal arrest in mitosis and the subsequent formation of mono-and multi-nucleated endopolyploid giant cells is incorporated under the collective term 'mitotic catastrophe' [1]. The mechanisms underlying such responses remain unclear [14]. Our group has previously described the morphological features of these endopolyploid cells and observed that certain stages of the cytological rearrangements that lead to their de-polyploidisation, and return to mitosis are partly reminiscent of meiotic prophase [5, 6]. Interestingly, ectopic expression of meiotic proteins of the so-called cancer/testis antigens group, namely SCP1 and SPO11, has been reported in the literature as a feature of progressing tumours [79] and it has been suggested that this phenomenon could represent a link between the malignant behaviour of tumours and a gametogenesis-like processes [1012].

One of the central signalling pathways involved in switching cells from mitosis to meiosis is regulated by the MOS kinase. During meiosis, MOS is translationally up-regulated, where it first stimulates the first reduction division of the cell and then further acts as a cytostatic factor to maintain the oocyte in metaphase arrest at meiosis II until fertilization occurs [13]. These separate functions are attributed to two different downstream targets of the MOS/MAPK pathway, cdk1 and Rsk90, respectively. In addition, MOS directly interacts with kinetochores thereby interrupting mitosis [14].

Meiosis functions to generate cells with a reduced number of chromosome sets. There are two obligate and interdependent requirements for this reduction division: (1) Sister chromatid cohesion and homologous chromosome pairing to facilitate the correct segregation and reduction of maternal and paternal chromosomes; (2) recombination between homologous chromosomes [15, 16]. Pivotal to these processes is the meiotic cohesin REC8 [17, 18] which sustains the cohesion between sister chromatids and particularly centromeres preventing separation until anaphase II [19]. Rec8 functions to ensure that both homolog pairing and reduction division occurs during meiosis. Recently, Rec8 dominant negative mutants have been shown to prevent synapse formation of homologs in mammalian cells [20], whilst in yeast mutants over-expressing REC8 fail to produce sister chromatid separation [21].

During pre-meiotic replication REC8 associates with an axial structure on the meiotic chromosomes which later forms the lateral element of the synaptonemal complex (SC) [22]. REC8 has been found to form complexes with the meiosis-specific recombinase DMC1 [23]. This enzyme is necessary for the Rad51-mediated stable DNA strand invasion and homology search which occurs during the homologous recombination stages of meiosis [24]. Other important proteins of the SC are SCP3 and SCP2 which form the lateral elements of the SC. A third protein, SCP1 forms the central element of the SC, providing a bridge to hold the two homologous chromosomes together, assisted by recombination chiasma between the homologs [2527]. REC8 colocalizes with another meiosis specific cohesin, STAG3. STAG3 stabilizes cohesion between sister chromatids during meiosis I and together with REC8 marks the lateral element of the SC [28].

Thus, REC8 and MOS, together with a number of specific cohesins and recombinases are important in the regulation and execution of meiosis, combining to achieve homologous recombination and chromosome separation/reduction. Although the molecular machinery for meiotic reduction divisions is largely understood, little is known regarding the regulation of reduction division in somatic polyploid cells which is thought to be a rare event [29]. We hypothesised that polyploid cells may have the same common regulators involved in reduction division as meiosis on the basis that meiosis has probably evolved as a means of reducing the chromosome number in asexual polyploid protists [10, 30]. Therefore, we sought to address whether the transformations observed in the endopolyploid tumour cells were linked with the ectopic expression of these genes. In this study we demonstrate the expression of several key meiotic prophase genes including MOS, SYCP1, REC8, DMC1, STAG3 and SYCP3 in tumour cells.


Cell lines and irradiation of cells

The Burkitt's lymphoma cell line Namalwa was obtained from the American Type Culture Collection (ATCC) and carries mutated p53 [31]. The TK6 and WI-L2-NS human lymphoblastoid cell lines were derived from the same WI-L2 isolate and were obtained from Dr. P. Olive (Vancouver, Canada). TK6 cells are p53 wild type and WI-L2-NS p53-mutated [32]. The p53 mutation status of all three cell lines was confirmed by sequencing analysis. Cells were grown in RPMI 1640 medium, 10 % Foetal Calf Serum (FCS; Gibco, Paisley, UK) at 37°C in a 5 % CO2 humidified incubator. Cells were maintained in log phase of growth for at least 24 hours prior to irradiation which was at a density of 5 × 105 cells/ml using a Gulmay D3 225 X-ray source at a dose rate of 0.77 Gy/min. Cell culture medium was replenished every 48–72 hours.

Mitotic counts and DNA flow cytometry

Mitotic counts were measured from cytospins stained for DNA. Metaphases, anaphases and telophases were counted per 1000 cells, in at least three independent experiments. DNA flow cytometry for detection of polyploid cells (>4C) was performed as described previously [32].

Isolation of mRNA and conversion into cDNA

mRNA was isolated using the microquickprep mRNA kit (Amersham Pharmacia Biotech UK Ltd, Little Chalfont, UK) and converted to cDNA using the first strand cDNA synthesis kit (Amersham Pharmacia Biotech UK Ltd) according to the manufacturer's instructions.


Reverse transcription polymerase chain reaction (RT-PCR) was performed in thin walled PCR tubes with 100 ng of cDNA, 100 ng of 5' and 3' primers, 1 unit (U) of DNA polymerase in the presence of dNTPs, 1 × reaction buffer and Taq polymerase (Promega, Southampton, UK). DNA was denatured at 95°C for 1 min, followed by 30 amplification cycles, using an annealing temperature of 56°C and extension at 72°C. The sequences of primers used are listed in Table 1. PCR products were analysed by electrophoresis in 1–2 % agarose gels and visualized under UV light after staining with ethidium bromide.
Table 1

Sequences of primers used in the RT-PCR experiments.



Reverse Primer























To verify the sequence of the RT-PCR products, additional PCR experiments were performed with Pfu polymerase rather than Taq. These products were gel purified and cloned into PCR-Blunt II- TOPO vector (Invitrogen Life Technologies, UK). Sequencing was performed with T7 and sp6 primers along with standard PCR dye based di-deoxy chain termination technology and analyzed on an AB Prism 377 sequencer (Perkin-Elmer Applied Biosystems, Warrington, UK). The MOS nucleotide sequence was submitted to GenBank (accession number AY279177).

Western blotting

Western blotting was performed on cytoplasmic cell lysates to detect MOS and β-actin proteins accordingly to the methods as previously described [33]. The anti-nuclear REC8 antibody (Santa Cruz Biotech.) was used to detect REC8. For MOS detection, 2 × 106 cells were lysed in 100 μl of 2× PSB, sonicated for 30 seconds, heated at 96°C for 5 minutes, resolved via 10% SDS-PAGE and transferred to PVDF membranes. After incubation with appropriately diluted primary antibodies (see Table 2), membranes were incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG (Sigma; Dorset, UK) for 1 hour at room temperature and washed. Antibody binding was visualized by SuperSignal West Pico Chemiluminescent Substrate (Pierce Biotechnology, Perbio Science UK Ltd., UK) before exposure to light-sensitive film (Hyperfilm ECL, Amersham Pharmacia Biotech, UK).
Table 2

Antibody source and usage

Primary antibodies

Secondary antibodies

Polyclonal goat anti-human REC8 (E-18):sc-15152 (Santa Cruz)

Rabbit anti-goat-Cy3 (Sigma)

Polyclonal rabbit anti-mouse REC8 antibody (602; kindly donated by Dr. C. Heyting, Wageningen, NL [23])

Goat anti-rabbit IgG-Texas red (Vector Laboratories Ltd., UK),

CREST serum against human kinetochore proteins (Acris Antibodies, Hiddenhausen, Germany)

Mouse anti-human IgG-FITC (Dr. MS Cragg)

Polyclonal rabbit anti-MOS (C237: sc-86; Santa Cruz Biotech;Wembley, UK)

Mouse anti-rabbit IgG-FITC (Sigma, Dorset, UK)

Polyclonal rabbit anti-SCP3 antiserum (kindly donated by Dr. C. Heyting, Wageningen, NL [46])

Goat anti-rabbit IgG-FITC (Vector Laboratories Ltd., UK),

Immunofluorescent (IF) staining

For immunofluorescent staining, harvested cells were suspended in FCS, cytospun onto poly-L-lysine coated microscope slides, fixed in absolute methanol for 10–20 minutes at -20°C. Slides were then rinsed in ice-cold acetone, semi-dried and washed in PBS. Detection of various proteins was performed with the respective antibodies according to[34]. The pairs of antibodies used and their source are presented in Table 2. Samples were counterstained with DAPI (0.5 μg/ml) (Molecular Probes, Cambridge, UK). Slides were mounted in mowiol (Harlow Chemical Company Ltd, UK), containing 0.1% citifluor (Agar Scientific, Stansted, UK). Images were taken with a Leica DM LS2 fluorescent microscope.


Translation of MOS is enhanced by irradiation in p53 mutated lymphoma cell lines

MOS was transcriptionally expressed in all three lymphoma cell lines, and no significant changes were detected following irradiation (Fig. 1A). However, when protein expression was assessed by Western blotting, a particularly pronounced accumulation of p39mos was observed in Namalwa cells after irradiation (Fig. 1B) with the peak levels of expression coinciding with the maximal metaphase arrest on day 3 (Fig. 2A and 2B). The p39mos expression was also elevated in WI-L2-NS cells after irradiation, which again coincided with the maximum mitotic arrest (in this case on day 2), albeit less pronounced (both the expression of p39mos and cell arrest) than that observed in the Namalwa cells. In contrast, p39mos protein was expressed at a very low level in p53 wild-type TK6 cells and its expression was not enhanced following irradiation. The expression level of p39mos also correlated with the amount of polyploid cells produced (Fig. 2C). These data suggest that the post-translational events responsible for the induction of MOS only occur in p53 mutated irradiated lymphoma cells following irradiation. Next we sought to examine the expression of the meiotic cohesin REC8.
Figure 1

Post transcriptional accumulation of p39mos protein in response to 10 Gy irradiation. (A) Transcription of MOS from Namalwa, WI-L2-NS or TK6 cells on different days after irradiation. Messenger RNA was first isolated from samples and then reverse transcribed to yield cDNA for semi-quantitative PCR. Primers for GAPDH were used to verify integrity and quantity of cDNA. Mos expression was observed in all 3 cell lines with minor differences seen during the five days after irradiation; (B) upper panel: in comparison to non-treated control (NT), accumulation of p39mos was detected by Western blotting on days 1 to 4 afterirradiation, with maximum expression observed on days 2–3 in Namalwa, and days 1 and 2 for WI-L2-NS cells. In TK6 cells, p39mos was not detectable after irradiation. Lower panel: for loading control PVDF membranes were re-blotted with mouse monoclonal anti-b-actin antibodies.
Figure 2

Metaphase arrest and levels of polyploidy in lymphoma cell-lines after 10 Gy irradiation. p53 mutated Namalwa cells show a pronounced arrest in metaphase as seen by the high mitotic index on day 3 to day 5 (A) and near absence of anaphases and telophases (B) for a period of almost 10 days. Metaphase arrest is smaller and shorter in W1-L2-NS; (C) typical changes in the levels of polyploidy observed by DNA flow cytometry in Namalwa, W1-L2-NS and TK6 cells. (C) Reprinted from Ivanov et al., 2003. Both mitotic and endo-cycling are abrogated in wt p53 TK6 cells, which do not survive this irradiation insult.

Expression of REC8 is enhanced after irradiation

Although transcribed at a low level in untreated cells, REC8 was substantially up-regulated following irradiation in all five independent experiments performed with the Namalwa cell-line (Figure 3A). Up-regulation was observed from day 3 until day 7–9 post-irradiation over the period during which the largest number of polyploid cells are present in the culture (Fig. 2C). REC8 was also expressed in WI-L2-NS cells and elevated following irradiation, albeit with different kinetics than that seen in Namalwa cells where a prominent increase in transcription was seen only from day 5. In contrast, in TK6 cells, REC8 was transcribed prior to irradiation but its expression fell afterwards. Due to almost all of the TK6 cells undergoing apoptosis by day 3, it was impossible to analyze expression levels on subsequent days. Western blot analysis performed for REC8 protein in Namalwa cells further confirmed the translation of this meiotic cohesion protein over this protracted period post-irradiation with a peak in protein expression on day 3 (Fig. 3B).
Figure 3

The expression of meiosis-specific genes DMC1, REC8, STAG3, SYCP1 and SYCP3 in irradiated lymphoma cells in the time-course post-irradiation: (A) Transcription of REC8, STAG3 and DMC1, shown by RT-PCR of mRNA isolated from WI-L2-NS, TK6 or Namalwa cells on different days post irradiation and from non-treated control cells (NT). Primers for actin were used to verify integrity and quantity of cDNA; (B) Expression of REC8 protein in Namalwa cells, detected by Western blotting (antibody from Santa Cruz). The highest level of transcription was detected on day 3. Lower panel: for loading control PVDF membranes were re-blotted with mouse monoclonal anti-b-actin antibodies. (C) Transcription of SYCP1 and SYCP3 shown by RT-PCR of mRNA isolated from non treated Namalwa cells or on day 7 post irradiation showing very weak background expression. NB: In this experiment three times as much cDNA was used for the WI-L2-NS non treated samples as was used for the WI-L2-NS samples post irradiation. This was done in order to verify the increase in transcription after irradiation treatment. Although the amount of cDNA taken for PCR with the REC8 primers is much smaller on day 5 post irradiation (as judged by beta actin level) it still shows obviously higher level of REC8 expression.

Distribution of REC8 in endopolyploid cells

Given the pronounced upregulation of REC8 following irradiation, we next assessed the localisation of REC8 in cells at various times after irradiation. As a positive control for REC8 staining we first assessed two different antibodies directed to REC8 on rat testes tissue and, as expected, we observed strongly positive staining in the primary spermatocytes (Fig. 4A insert). Using the same antibodies, we then assessed the expression of REC8 in the lymphoma cells. Untreated Namalwa cells in interphase or undergoing mitosis were negative for REC8. Interestingly, however, a few bright, large, REC8-positive foci were observed in the chromatin of rare mitotic cells undergoing arrest in metaphase (data not shown).
Figure 4

In situ localisation of REC8 post-mitotic catastrophe in endopolyploid Namalwa cells: (A) REC8 (red) appears on day 3 in the metaphase-arrested cells which, as judged by the adhered swollen chromosomes, undergo restitution into endopolyploid cells. DNA counterstained by DAPI (blue) (insert- rat testis control for Rec8); (B) IF double-staining for kinetochores/centromeres by CREST antibody (FITC, green) and REC8 (red) in a polyploid interphasic cell, where interaction of REC8 foci with kinetochores/centromeres is shown; arrow and arrowhead indicate the insertion of several REC8 foci in CREST-positive arrayed structures; the image insert shows a higher magnification of a centromere doublet cohesed with a focus of REC8.

Following irradiation of Namalwa cells, bright REC8-positive foci appeared in about 10–15% of the cells on day 3. These data are in accordance with the western blot REC8 protein expression coincident with the peak of mitotic arrest. REC8 was localised within the arrested aberrant metaphases characterised by the swollen and adhered chromosomes (Fig 4A), evidently undergoing restitution into interphase. After day 3, the amount of REC8 staining increased in the nuclei of subsequent endopolyploid interphase cells. During this period (day 3–6), DNA endoreduplication and repair by homologous recombination were observed as documented by us previously [5, 35, 36].

Subsequently, we assessed if REC8 was associated with centromeres by combining immunostaining with REC8 and a CREST antibody known to detect kinetochore proteins associated with centromeres. This staining revealed REC8- and CREST-positive foci to be associated and juxta-posed from day 5 to day 9–11, although somewhat irregularly. REC8 foci were seen inserted between doublets or chains of CREST-positive foci (Fig. 4B).

Expression of other meiosis-specific genes

Next, we assessed whether other meiosis specific proteins were expressed in the lymphoma cells. The DMC1 gene encodes for a meiosis specific recombinase from the RecA family and appears to act in cooperation with REC8 [23] and Rad51 [37]. We found by RT-PCR that DMC1 was also expressed, both in irradiated and non-treated samples of all three cell lines, with a prominent decrease after irradiation in the p53 wild-type TK6 cells (Fig. 3A). We also found that STAG3, a meiosis-specific cohesin, is transcribed in all three cell lines, although with no apparent change in transcription after irradiation. The translational expression of Rad51 in endopolyploid cells, a recombinase engaged in DNA repair, has previously been shown by us to occur following irradiation in these same p53 mutated cell lines [33]. Studies of the genes involved in the formation of the synaptonemal complex, SYCP1 and SYCP3 revealed some weak background expression in Namalwa cells. Although only weakly transcribed, the identity of these PCR products was confirmed by sequencing. The transcriptional expression of these genes was not elevated by irradiation (Fig. 3C).

On day 6 post-irradiation, approximately 8% of irradiated Namalwa cell nuclei displayed atypical weak SCP3 staining by IF in the perinuclear region (not shown).


In this study we have investigated the expression of several meiotic genes in p53 wild-type and p53 mutated lymphoma cells both before and after an irradiation insult that induces mitotic catastrophe. This study reveals that a group of previously well defined meiosis-specific proteins are clearly upregulated in the p53 mutated cells after DNA damage with irradiation. In particular, the meiosis-regulatory protein, MOS, was strongly post-transcriptionally up-regulated in the Namalwa and WIL2NS cells after irradiation. This up-regulation was only apparent in p53 mutated cells and was lacking from the wild-type TK6 cells, implying that up-regulation of MOS by DNA damage is inhibited by wild type p53 function. Interestingly, this elevation in MOS protein was a post-translational event as transcription remained constant after irradiation. Therefore increases in MOS may arise from either increased translation from the mRNA or increased protein stability. For example, post-translational modification of the MOS protein by (auto)phosphorylation on Ser-3 could lead to its increased stability and decreased proteasome-mediated degradation [14].

This observation of mos upregulation in p53 mutated cells, is in line with data of Fukasawa and Vande Woude [38] who demonstrated that only p53-/- somatic cells can tolerate high levels of MOS and the subsequent downstream elevation of MAPK activity. It should also be noted that up-regulation of MOS protein has been previously shown in human ovarian cancer cells arrested at the spindle checkpoint by microtubule-damaging agents [39]. Hence, the quantitative and temporal relationship between MOS up-regulation and the arrest in the spindle checkpoint were also found in that system, although a different type of tumour cell was used and a different metaphase arrest strategy employed. These data strengthen the notion that MOS expression may be directly involved in the metaphase arrest in mitotic catastrophe.

During the homologous recombination processes of meiosis, Rad51 is known to cooperate with the meiotic cohesin Rec8 and meiotic recombinase DMC1 [37]. It is striking that in the irradiated p53 mutant lymphoid tumours shown here, we observed the expression of a major meiotic cohesin REC8 and the meiotic recombinase DMC1. In addition to its potential role in DNA recombination and repair, the chromatid-cohesing function of REC8 may also provide for the induction of polyploidising ('catastrophic') mitosis. Whether it represents an adaptive response which favours escape from mitotic cell death, providing an option for the formation of giant cells, additional DNA repair and their segregation by somatic reduction still remains to be elucidated.

An interesting and unexpected finding was that a number of other meiotic prophase-specific genes are also expressed in the lymphoma cell lines. Importantly, the induced activation of these meiotic genes seen in the p53 mutated cell lines was not observed in the wild-type p53 TK6 cells. In accord, TK6 cells produce a very small polyploid cell fraction after irradiation, approximately 6 to 10 times less than WI-L2-NS or Namalwa cells and do not survive the 10 Gy irradiation dose (see Fig. 1).

It is noteworthy that the meiosis-specific genes that were observed by us to be aberrantly expressed in the p53 mutated lymphoma cells (MOS, REC8, DMC1, STAG3, SYCP1, and SYCP3) can all be classified as cancer/testis antigens as defined by Simpson et al. [12]. Many of the cancer/testis gene products belong to a broad and ever expanding group of tumour antigens [7, 10] and some have been used, with various success rates, as targets for vaccine therapy in clinical trials [40].

To our knowledge, four of these meiotic prophase-associated genes (REC8, DMC1, STAG3 and SYCP3) are reported to be expressed in malignant tissue for the first time. Interestingly, at least a proportion of these meiosis specific genes appear to be associated with the induction of mitotic catastrophe and the generation of endopolyploid tumour cells.

Finally, recent advances in long-term video-microscopy have found that the endopolyploid cells resulting from mitotic catastrophe appear to have some reproductive potential [4, 4145]. Given these observations and the potential importance of the meiosis-specific genes in the response of p53 mutated tumour cells to genotoxic treatment, further study of these meiotic genes in tumours may reveal novel therapeutic strategies.


List of abbreviations used




synaptonemal complex



We wish to acknowledge Dr. Bodo Liebe (Max-Planck-Inst. for Molecular Genetics, Berlin) and Dr. Harry Scherthan (Inst. of Radiation Biology, Munich) for their help with SCP3 staining and for the helpful discussions. Many thanks go to Mrs. Galina Boka from the Latvian Oncology Centre for her help with cell irradiation. This work was performed with financial assistance from grant No 02. 040 of the Latvian Scientific Council and a grant from the Royal Society of London for the Joint Research Project 'The role of giant cells in mechanisms of tumour resistance and survival after genotoxic insult' (2002–2003) enabling exchange visits between Southampton and Riga.

Authors’ Affiliations

Biomedical Research and Study Centre, Latvian University
Paterson Institute Cancer Research, Christie Hospital, Cancer Sciences Division University of Manchester
Tenovus Research Laboratory, Cancer Sciences Division, School of Medicine, Southampton University Hospital
Walter and Eliza Hall Institute of Medical Research
Oncology Center of Latvia


  1. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science. 1994, 266 (5192): 1821-1828.View ArticlePubMedGoogle Scholar
  2. Roninson IB, Broude EV, Chang BD: If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug ResistUpdat. 2001, 4 (5): 303-View ArticleGoogle Scholar
  3. Erenpreisa J, Cragg MS: Mitotic death: a mechanism of survival? A review. Cancer Cell Int. 2001, 1 (1): 1-View ArticlePubMedPubMed CentralGoogle Scholar
  4. Ianzini F, Mackey MA: Development of the large scale digital cell analysis system. RadiatProtDosimetry. 2002, 99 (1-4): 289-Google Scholar
  5. Erenpreisa JA, Cragg MS, Fringes B, Sharakhov I, Illidge TM: Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line. Cell BiolInt. 2000, 24 (9): 635-Google Scholar
  6. Erenpreisa J, Kalejs M, Ianzini F, Kosmacek EA, Mackey MA, Emzinsh D, Cragg MS, Ivanov A, Illidge TM: Segregation of genomes in polyploid tumour cells following mitotic catastrophe . Cell Biol Int. 2005, 1005-1011.Google Scholar
  7. Scanlan MJ, Simpson AJ, Old LJ: The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 2004, 4: 1-PubMedGoogle Scholar
  8. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M: Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. ProcNatlAcadSciUSA. 1998, 95 (9): 5211-View ArticleGoogle Scholar
  9. Koslowski M, Tureci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U: Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res. 2002, 62 (22): 6750-PubMedGoogle Scholar
  10. Kalejs M, Erenpreisa J: Cancer/testis antigens and gametogenesis: a review and "brain-storming" session. Cancer Cell Int. 2005, 5 (4): 4-View ArticlePubMedPubMed CentralGoogle Scholar
  11. Old LJ: Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun. 2001, 1: 1-PubMedGoogle Scholar
  12. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ: Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005, 5 (8): 615-625.View ArticlePubMedGoogle Scholar
  13. Tachibana K, Tanaka D, Isobe T, Kishimoto T: c-Mos forces the mitotic cell cycle to undergo meiosis II to produce haploid gametes. ProcNatlAcadSciUSA. 2000, 97 (26): 14301-View ArticleGoogle Scholar
  14. Sagata N: What does Mos do in oocytes and somatic cells?. Bioessays. 1997, 19 (1): 13-View ArticlePubMedGoogle Scholar
  15. Walker MY, Hawley RS: Hanging on to your homolog: the roles of pairing, synapsis and recombination in the maintenance of homolog adhesion. Chromosoma. 2000, 109 (1-2): 3-View ArticlePubMedGoogle Scholar
  16. Bishop DK, Zickler D: Early decision; meiotic crossover interference prior to stable strand exchange and synapsis. Cell. 2004, 117 (1): 9-View ArticlePubMedGoogle Scholar
  17. Klein F, Mahr P, Galova M, Buonomo SB, Michaelis C, Nairz K, Nasmyth K: A central role for cohesins in sister chromatid cohesion, formation of axial elements, and recombination during yeast meiosis. Cell. 1999, 98 (1): 91-View ArticlePubMedGoogle Scholar
  18. Parisi S, McKay MJ, Molnar M, Thompson MA, van der Spek PJ, Drunen-Schoenmaker E, Kanaar R, Lehmann E, Hoeijmakers JH, Kohli J: Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans. MolCell Biol. 1999, 19 (5): 3515-Google Scholar
  19. Watanabe Y, Nurse P: Cohesin Rec8 is required for reductional chromosome segregation at meiosis. Nature. 1999, 400: 461-View ArticlePubMedGoogle Scholar
  20. Xu H, Beasley MD, Warren WD, van der Horst GT, McKay MJ: Absence of mouse REC8 cohesin promotes synapsis of sister chromatids in meiosis. Dev Cell. 2005, 8 (6): 949-961.View ArticlePubMedGoogle Scholar
  21. Kitajima T, Kawashima S, Watanabe Y: The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis. Nature. 2003, 427: 510-View ArticleGoogle Scholar
  22. van Heemst D, Heyting C: Sister chromatid cohesion and recombination in meiosis. Chromosoma. 2000, 109 (1-2): 10-View ArticlePubMedGoogle Scholar
  23. Eijpe M, Offenberg H, Jessberger R, Revenkova E, Heyting C: Meiotic cohesin REC8 marks the axial elements of rat synaptonemal complexes before cohesins SMC1beta and SMC3. JCell Biol. 2003, 160 (5): 657-View ArticleGoogle Scholar
  24. Shinohara A, Shinohara M: Roles of RecA homologues Rad51 and Dmc1 during meiotic recombination. CytogenetGenome Res. 2004, 107 (3-4): 201-View ArticleGoogle Scholar
  25. Yuan L, Liu JG, Hoja MR, Lightfoot DA, Hoog C: The checkpoint monitoring chromosomal pairing in male meiotic cells is p53-independent. Cell DeathDiffer. 2001, 8 (3): 316-Google Scholar
  26. Colaiacovo MP, MacQueen AJ, Martinez-Perez E, McDonald K, Adamo A, La Volpe A, Villeneuve AM: Synaptonemal complex assembly in C. elegans is dispensable for loading strand-exchange proteins but critical for proper completion of recombination. DevCell. 2003, 5 (3): 463-Google Scholar
  27. Liebe B, Alsheimer M, Hoog C, Benavente R, Scherthan H: Telomere attachment, meiotic chromosome condensation, pairing, and bouquet stage duration are modified in spermatocytes lacking axial elements. MolBiolCell. 2004, 15 (2): 827-Google Scholar
  28. Prieto I, Tease C, Pezzi N, Buesa JM, Ortega S, Kremer L, Martinez A, Martinez AC, Hulten MA, Barbero JL: Cohesin component dynamics during meiotic prophase I in mammalian oocytes. Chromosome Res. 2004, 12 (3): 197-213.View ArticlePubMedGoogle Scholar
  29. Storchova Z, Pellman D: From polyploidy to aneuploidy, genome instability and cancer. NatRev MolCell Biol. 2004, 5 (1): 45-Google Scholar
  30. Erenpreisa J, Kalejs M, Cragg MS: Mitotic catastrophe and endomitosis in tumour cells: An evolutionary key to a molecular solution. Cell BiolInt. 2005, 29: 1012-1018.Google Scholar
  31. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW: Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 1993, 53 (20): 4776-4780.PubMedGoogle Scholar
  32. Amundson SA, Xia F, Wolfson K, Liber HL: Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mutat Res. 1993, 286 (2): 233-241.View ArticlePubMedGoogle Scholar
  33. Ivanov A, Cragg MS, Erenpreisa J, Emzinsh D, Lukman H, Illidge TM: Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. JCell Sci. 2003, 116 (Pt 20): 4095-View ArticleGoogle Scholar
  34. Scherthan H, Jerratsch M, Li B, Smith S, Hulten M, Lock T, de Lange T: Mammalian meiotic telomeres: protein composition and redistribution in relation to nuclear pores. MolBiolCell. 2000, 11 (12): 4189-Google Scholar
  35. Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA: Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell BiolInt. 2000, 24 (9): 621-Google Scholar
  36. Erenpreisa J, Ivanov A, Cragg M, Selivanova G, Illidge T: Nuclear envelope-limited chromatin sheets are part of mitotic death. HistochemCell Biol. 2002, 117 (3): 243-View ArticleGoogle Scholar
  37. Gerton JL, Hawley RS: Homologous chromosome interactions in meiosis: diversity amidst conservation. Nat Rev Genet. 2005, 6 (6): 477-487.View ArticlePubMedGoogle Scholar
  38. Fukasawa K, Vande Woude GF: Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. MolCell Biol. 1997, 17 (1): 506-Google Scholar
  39. Ling YH, Yang Y, Tornos C, Singh B, Perez-Soler R: Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res. 1998, 58 (16): 3633-PubMedGoogle Scholar
  40. Stevanovic S: Identification of tumour-associated T-cell epitopes for vaccine development. NatRev Cancer. 2002, 2 (7): 514-View ArticlePubMedGoogle Scholar
  41. Ianzini F, Mackey MA: Mitotic Catastrophe. Apoptosis and Senescence in Cancer Chemotherapy and Radiotherapy. Edited by: Gewirtz , Holt , Grant . 2005, Humana PressGoogle Scholar
  42. Prieur-Carrillo G, Chu K, Lindqvist J, Dewey WC: Computerized video time-lapse (CVTL) analysis of the fate of giant cells produced by X-irradiating EJ30 human bladder carcinoma cells. Radiat Res. 2003, 159 (6): 705-712.View ArticlePubMedGoogle Scholar
  43. Sundaram M, Guernsey DL, Rajaraman MM, Rajaraman R: Neosis: a novel type of cell division in cancer. Cancer BiolTher. 2004, 3 (2): 207-Google Scholar
  44. Mackey MA, Anderson KR, Bresnahan LE, Domann FE, Gallardo G, Ianzini F, Kosmacek EA, Li Y, Sonka M, Spitz DR, Sun Y, Wang L, Yang F: The Large Scale Digital Cell Analysis System: A Unique Tool for the Study of Molecular and Cellular Phenomena in Living Cell Populations. Molecular Imaging. 2003, 2: 226-Google Scholar
  45. Ianzini F, Bresnahan L, Wang L, Anderson K, Mackey MA: The Large Scale Digital Cell Analysis System and its Use in the Quantitative Analysis of Cell Populations. The Second Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine and Biology. Edited by: Dittmar A, Beebe E. 2002, Piscataway, NJ , EEE Press, 470-475.Google Scholar
  46. Lammers JH, Offenberg HH, van Aalderen M, Vink AC, Dietrich AJ, Heyting C: The gene encoding a major component of the lateral elements of synaptonemal complexes of the rat is related to X-linked lymphocyte-regulated genes. Mol Cell Biol. 1994, 14 (2): 1137-1146.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:


© Kalejs et al; licensee BioMed Central Ltd. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.